Key result
PCAT radiomics model discriminates elevated LDL-C with an AUROC of ~0.72.
Why the study?
Pericoronary adipose tissue is an established imaging biomarker of coronary inflammation, but the influence of LDL-C on it remains unclear.
Are CCTA-based pericoronary adipose tissue radiomic features associated with elevated LDL-C levels in adult patients?
Cross-Sectional (n=150)
No
Are CCTA-based pericoronary adipose tissue radiomic features associated with elevated LDL-C levels in adult patients?
Effect estimate: AUROC 0.724
Elevated LDL-C levels are significantly associated with increased spatial heterogeneity and high gray-level clustering in pericoronary adipose tissue on CCTA, providing noninvasive imaging evidence of the link between lipid burden and local coronary inflammation.
May link LDL-C to pericoronary inflammation on CCTA; hypothesis-generating and requires prospective validation before clinical use.
Background: Pericoronary adipose tissue (PCAT) is an established imaging biomarker of coronary inflammation; however, the influence of low-density lipoprotein cholesterol (LDL-C) remains unclear. This study aimed to explore the associations between PCAT and LDL-C using coronary computed tomography angiography (CCTA)-based radiomics. Methods: This retrospective study stratified 150 patients undergoing CCTA into two groups according to serum LDL-C levels (≥3.4 mmol/L vs. <3.4 mmol/L). A total of 288 radiomic features were extracted from the PCAT surrounding the left anterior descending artery, left circumflex artery, and right coronary artery. After the initial filtering using the Wilcoxon rank-sum test, univariate logistic regression and Pearson correlation analyses were applied to identify features associated with elevated LDL-C levels. Key features were further validated using a gradient boosting machine (GBM) ensemble model combined with Shapley Additive Explanations (SHAP) analysis. Results: < 0.01). The GBM model achieved the best performance, with an area under the receiver operating characteristic curve (AUROC) of 0.889 in the training set and 0.724 in an internal hold-out test set. SHAP analysis identified first-order energy and large-area high gray-level features as the most important contributors to the discrimination of high LDL-C status. Conclusion: Elevated LDL-C levels are significantly associated with increased spatial heterogeneity and high gray-level clustering in PCAT, thereby providing imaging-based evidence supporting the association between LDL-C and PCAT.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) conducted a cross-sectional in Elevated LDL-C / Coronary Inflammation (n=150). Elevated LDL-C (≥3.4 mmol/L) vs. Lower LDL-C (<3.4 mmol/L) was evaluated on Discrimination of elevated LDL-C status using a gradient boosting machine (GBM) radiomics model in an internal hold-out test set (AUROC 0.724). Elevated LDL-C levels were significantly associated with increased spatial heterogeneity and high gray-level clustering in pericoronary adipose tissue, with an ensemble radiomics model achieving an AUROC of 0.724 for discriminating high LDL-C status.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: